Immunome IMNM
NASDAQ IMNM
$20.90 +0.01 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunome (IMNM) Short-term Investments (2023 - 2026)

Updated

Immunome's Short-term Investments came in at $302.3 million for Q2 2026, up 143.4% from $124.2 million a year earlier.

Analysis

Immunome (IMNM) Short-term Investments (2023 - 2026) Analysis & Trends

At the end of FY2024, Immunome's Short-term Investments was $73.95 million, up 87.4% from FY2023.

  • Going back by year, Short-term Investments was $39.46 million in FY2023.
  • The Q2 2026 figure represents the highest quarterly Short-term Investments in data going back to Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Immunome 2.37 Bn 340.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 302.30 Mn
Jun 30, 2025 124.20 Mn
Mar 31, 2025 59.71 Mn
Dec 31, 2024 73.95 Mn
Sep 30, 2024 84.60 Mn
Jun 30, 2024 113.02 Mn
Mar 31, 2024 40.00 Mn
Dec 31, 2023 39.46 Mn
API Access

Immunome Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=IMNM&period=max&api_key=YOUR_API_KEY